echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Over 1 billion U.S. dollars!

    Over 1 billion U.S. dollars!

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 21, Sanofi announced that it has reached an agreement to acquire Amunix Pharmaceuticals (hereinafter referred to as "Amunix") to develop next-generation biological products


    The T-cell binder (TCE) blinatumomab has previously demonstrated that redirecting T cells can extend the remission time of cancer patients


    The XTEN platform introduces the precise modification of recombinant protein engineering into the field of polymer chemistry


    Reference materials:

    [1] Sanofi to acquire Amunix immuno-oncology pipeline with next generation Conditionally Activated Biologics.


    (The original text has been deleted)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.